Trial intelligence / Profile preview

TheraCal LC for Pulp Capping in Primary Molars

NCT05167123Phase 4Completed

Sponsor
Ain Shams University
Start
Sep 2019
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of TheraCal LC in reversible pulpitis, sponsored by Ain Shams University. Started Sep 2019; status: completed.

02

Drugs

TheraCal LC
03

Conditions

reversible pulpitis

Beyond the preview

Go deeper on NCT05167123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05167123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call